Project Grant K01HL183853
Award Date 9/1/26
Completion Date 8/31/31
Dollars Obligated $153K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
- The National Heart, Lung, and Blood Institute awarded the University of Texas Health Science Center at Houston $794,406 on July 1, 2026, for a Project Grant (R01HL181234) to optimize and evaluate an implementation strategy to improve use of classroom-based physical activity approaches in elementary schools. This award is funded under the Cardiovascular Diseases Research program (CFDA 93.837). The recipient will develop and refine a multifaceted implementation strategy designed to promote two...
- The National Heart, Lung, and Blood Institute awarded the University of Texas at Arlington $113,788 on August 14, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate how changes in shared public activity spaces—such as walking trails, parks, and sidewalks—affect long-term hypertension risk trajectories in aging adults. The research uses longitudinal data from the nationally representative Health and Retirement Study to identify physical activity-related pathways...
- The National Institutes of Health National Heart, Lung, and Blood Institute awarded The University of Texas Southwestern Medical Center $150,104 on March 2, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate cardiovascular and respiratory responses to physical activity and heat stress in burn survivors. The recipient will conduct research on thermoregulation and pulmonary function impairment in burn survivors, who experience exaggerated increases in core...
- The National Heart, Lung, and Blood Institute awarded The Regents of the University of Colorado (University of Colorado-Denver) $168,691 on August 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to refine, augment, and pilot test an affect-based physical activity promotion program for cancer survivors at elevated risk of cardiovascular disease. The award funds a K01 Career Development Award with a five-year period of performance through July 31, 2031. Work is...
- The National Heart, Lung, and Blood Institute awarded the Trustees of Indiana University $277,375 under the Cardiovascular Diseases Research program (CFDA 93.837) on July 25, 2026, to conduct a cluster randomized controlled trial assessing the feasibility and effect of Health Strides, a six-month, multi-level physical activity intervention targeting Head Start staff. The intervention combines workplace-level and individual-level components. The workplace component establishes a wellness...
- The National Heart, Lung, and Blood Institute awarded Duke University $136,646 under the Cardiovascular Diseases Research program (CFDA 93.837) on September 19, 2025, to conduct a K01 Career Development Award examining sex differences in barriers and predictors of physical activity participation during and following cardiac rehabilitation. The award is structured as a Project Grant with performance through August 31, 2030, at Duke University in Durham, North Carolina. The recipient will...
- The National Institute of Child Health and Human Development awarded The Regents Of The University Of Colorado (doing business as University Of Colorado-Denver) $636,728 for a Project Grant in Child Health and Human Development Extramural Research (CFDA 93.865) effective August 4, 2026. The award funds a multicenter prospective study measuring physical activity recovery in children who survive acute respiratory disease requiring invasive mechanical ventilation in pediatric intensive care...
- The National Heart, Lung, and Blood Institute awarded The Regents Of The University Of Colorado (University of Colorado-Denver) $169,225 on July 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to support a K23 career development grant. The award funds Dr. Rochelle Cason-Wilkerson's research into targeted intervention and process strategies (TIPS) to enhance health outcomes and reduce attrition in preschool-aged children with obesity. The research adapts an existing...
- The National Heart, Lung, and Blood Institute awarded the University of Massachusetts Medical School $173,929 on August 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to support a Mentored Research Scientist Development Award (K01) for Dr. Goulding's training and research in cardiovascular disease prevention and management in youth with hypertension. The award funds training, mentorship, and research development for Dr. Goulding, an assistant professor and behavioral...
- The National Institutes of Health National Heart Lung and Blood Institute awarded the University of Texas Medical Branch at Galveston $1.575 million on September 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to examine how movement-related anxiety affects physical recovery and activity levels in women following major acute cardiovascular events. The research will recruit 489 women aged 18 or older hospitalized for acute cardiac events and treated with percutaneous...